StockData
Summit Therapeutics Inc. logo

Summit Therapeutics Inc. (SMMT) stock

SMMTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$10.67−1.15 (-9.73%)

Close on Nov 17, 2026Market cap $8.51BP/E –Yield –

Summit Therapeutics operating margin

Operating margin is operating income as a percentage of revenue.

Summit Therapeutics's operating margin for the twelve months ending Jun 30, 2023 was -268266.8%. For fiscal 2022 it was -10225.4%, against -4764.3% the year before.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2022Dec 31, 2022-10225.4%−5461.1
FY2021Dec 31, 2021-4764.3%−4773.7
FY2019Jan 31, 20199.4%–

Quarterly operating margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q3 FY2022CQ3 2022Sep 30, 2022-7700.0%−6211.4
Q2 FY2022CQ2 2022Jun 30, 2022-5400.9%+36230.7
Q1 FY2022CQ1 2022Mar 31, 2022-8863.2%−49.1
Q4 FY2021CQ4 2021Dec 31, 2021-10377.3%–
Q3 FY2021CQ3 2021Sep 30, 2021-1488.6%–
Q2 FY2021CQ2 2021Jun 30, 2021-41631.6%–
Q1 FY2021CQ1 2021Mar 31, 2021-8814.1%–

More Summit Therapeutics figures

See a number that looks wrong?